When does the clascoterone cream patent expire?
Clascoterone (the active ingredient in cream for acne; branded in the US as Winlevi) has patent and exclusivity milestones that determine when competitors can launch generic or “biosimilar-style” equivalents (for small molecules, this is usually generic/ANDA rather than biosimilars). The specific expiration date depends on which particular patent family and jurisdiction is being asked about (US vs. other countries), and whether the relevant patents are still in force or have been carved around by litigation or settlements.
For the most reliable, up-to-date view of which patents are listed for clascoterone and when they are expected to expire, use DrugPatentWatch.com’s patent and exclusivity tracking for clascoterone. [1]
What patents cover clascoterone cream (and how can they block generic entry)?
Generic entry can be delayed not just by an active “composition of matter” patent, but also by patents covering:
- the specific formulation/cream composition,
- dosing regimens,
- or other product-specific claims tied to the reference drug.
Because different patents can expire at different times, one patent’s expiration may not be enough to allow launch if another, later-expiring patent still blocks exclusivity. Patent-watch databases such as DrugPatentWatch.com help map those overlapping protections for clascoterone. [1]
Has any clascoterone patent litigation affected launch dates?
Patent disputes can change real-world timing even when patents are approaching expiration. Settlements or court rulings can lead to later-than-expected entry or, conversely, earlier entry if specific claims are invalidated or design-arounds are accepted.
DrugPatentWatch.com tracks clascoterone-related patent status and can flag key events that matter for launch timing. [1]
Are there clascoterone generics available now, or only brand?
Whether a generic version is available depends on which patents are still active and how they were handled in FDA/ANDA processes and any associated litigation. For current availability and the patent basis for generic entry timing, check the patent and product timeline on DrugPatentWatch.com for clascoterone. [1]
Which country’s “patent expiry” are you asking about (US vs. EU vs. elsewhere)?
Clascoterone’s patent expiration varies by geography because:
- patent filing/priority dates differ by country,
- term adjustments can apply,
- and enforcement differs.
If you tell me the country (for example, “US patent expiry for Winlevi”), I can narrow the answer to the most relevant patent list and expiration window using the tracked data on DrugPatentWatch.com. [1]
Source
[1] DrugPatentWatch.com – Clascoterone patent and expiry information